This report has been updated. Click here to view latest edition.

If you have previously purchased the archived report below then please use the download links on the right to download the files.

RFID for Healthcare and Pharmaceuticals 2009-2019

This unique report gives a full technical and market analysis

By
Show All Description Contents, Table & Figures List FAQs Pricing Related Content
The RFID business is growing so fast that few applicational sectors can beat that scorching rate of growth. Healthcare and pharmaceuticals is one of them thanks to the new tagging of drugs, real time location of staff and patients and other developments including automated error prevention. This unique report gives a full technical and market analysis illustrated by 70 case studies. It is a vital resource for the healthcare profession and all who wish to support it. We separately assess the opportunity for both passive and active tags in pharmaceuticals and healthcare in the following sectors:
  • Pharmaceutial drugs
  • Medical disposables and other items
  • Pallets and cases
  • Laundry
  • People
  • Secure Access
  • Conveyances, vehicles, assets
  • Real Time Locating Systems (RTLS)
  • Sensor based applications
 
RFID in healthcare and pharmaceuticals has special requirements, unquantifiable benefits (safety, security, reputation, brand protection etc) and sometimes tolerance of longer paybacks for such reasons can often lead to very profitable and worthwhile business for suppliers. Extensive benchmarking in the business leads to rapid dissemination of the multiple benefits to users of given schemes and great pressure on the laggards to catch up.
Rapid increase in adoption
The market for RFID tags and systems in healthcare will rise rapidly from $94.6 million in 2009 to $1.43 billion in 2019. Primarily, this will be because of item level tagging of drugs and other medical disposables and Real Time Locating Systems (RTLS) for staff, patients and assets to improve efficiency, safety and availability and to reduce losses. The tagging of the packs of blisterpacks and the plastic bottles used by patients is primarily a US phenomenon driven by the need for improved anticounterfeiting but there will be great improvements in theft deterrence and improved stock control and recalls.
 
Ten year forecasts for passive tags in healthcare and pharmaceuticals by tag value
Source: IDTechEx
 
This report analyses 10 year forecasts of RFID in the healthcare and pharmaceutical sector.
Free RFID Knowledgebase
Purchasers of this report obtain free access to the IDTechEx RFID Knowledgebase for one year. This is the world's largest searchable database of RFID projects, currently running at over 4400 case studies in 123 countries involving over 4440 organisations and linked to 770 relevant company slideshows and audio. It is continuously updated so new projects relevant to this report can be accessed as soon as they come in.
Analyst access from IDTechEx
All report purchases include up to 30 minutes telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.
Further information
If you have any questions about this report, please do not hesitate to contact our report team at research@IDTechEx.com or call one of our sales managers:

AMERICAS (USA): +1 617 577 7890
ASIA (Japan and Korea): +81 3 3216 7209
EUROPE (UK) +44 1223 812300
EXECUTIVE SUMMARY AND CONCLUSIONS
1.INTRODUCTION
1.1.Some of the relevant challenges in healthcare and pharmaceuticals and how RFID can help
1.1.Technical performance for active RFID in crowded environments as a function of frequency in the view of Savi Technology
1.1.Relevant challenges in healthcare and pharmaceuticals
1.2.Radio Frequency Identification
1.2.UWB frequency spread compared with some alternative active RFID bands in the microwave region
1.2.Some tasks performed by RFID
1.3.The commonly used licence free frequencies for active RFID
1.3.Real Time Locating Systems
1.4.Trend of frequencies
1.4.1.Form of Active RFID
1.4.2.Radio regulations are changing
1.4.3.No ideal frequency for everything
1.4.4.Ultra Wide Band (UWB)
1.5.Privacy issues
2.LOCATION AND STATUS OF STAFF, VISITORS, PATIENTS AND FIXED ASSETS
2.1.Challenges
2.1.Examples of needs and concerns about RTLS in healthcare
2.1.Radianse view of the relative merits of some RTLS technologies
2.2.Example of Zonal RTLS
2.2.Wherify view of RTLS options
2.2.Primary benefits of RTLS
2.3.Detailed needs, concerns, impediments for RTLS in healthcare
2.3.Comparison of today's favourite RTLS systems in healthcare
2.3.A typical business case for parasitic WiFi over conventional RTLS. An increasing proportion of hospitals seem to be convinced enough to buy such a radio fingerprinting solution.
2.4.How does the system work?
2.4.Examples of companies with RTLS systems or appropriate parts and services
2.4.RTLS technology
2.4.1.Definition of RTLS
2.5.Choice of technologies
2.5.Examples of suppliers and developers of RTLS systems
2.5.Ekahau WiFi tag
2.5.1.Radianse view of technologies
2.5.2.Zonal
2.5.3.Radio fingerprinting
2.5.4.Triangulation and Time Difference of Arrival (TDOA)
2.5.5.Global Positioning System (GPS)
2.5.6.Received Signal Strength Indication (RSSI)
2.5.7.GSM and GPRS
2.6.Required characteristics of an indoor positioning solution
2.6.Suppliers
2.6.Monitoring system for personnel tags
2.7.Zonal personnel tracking system
2.7.RTLS Case studies: Indoor Positioning Systems for people
2.7.Equipment Rental Costs: Financial Results
2.7.1.IPS in hospitals
2.7.2.Nagoya Ekisaikai Hospital Japan
2.7.3.Alexandra Hospital/ Singapore National University Hospital, Singapore
2.7.4.Mercy Hospital USA
2.7.5.Brigham & Women's Hospital, USA
2.7.6.Borgess Medical Center patients USA
2.7.7.City halls Japan
2.7.8.Saarbrucken Clinic Germany
2.7.9.Presbyterian Hospital USA
2.7.10.Changgen Memorial Hospital Taiwan
2.7.11.Tung Yuan Hospital in Hsinchu, Taiwan
2.7.12.Hospitals Israel
2.7.13.Werribee Mercy Hospital, Australia
2.7.14.Wirral Hospital UK
2.7.15.Birmingham Heartlands and Solihull NHS Trust UK
2.7.16.Academic Medical Centre The Netherlands
2.7.17.Sun Yat-Sen Cancer Center Taiwan
2.7.18.Lancaster General Hospital USA
2.7.19.Bangkok Hospital Thailand
2.8.Associate Satisfaction: Nursing Satisfaction Scores
2.8.RTLS case studies - assets and supplies
2.8.Using RFID to guide people
2.8.1.Jackson Memorial Hospital USA
2.8.2.Beth Israel Deaconess Medical Center USA
2.8.3.Bon Secours Health System, USA
2.8.4.Salmon Creek Hospital USA
2.8.5.Vanderbilt Children's Hospital USA
2.8.6.Washington Hospital Center, USA
2.8.7.Hospital of the University of Pennsylvania USA
2.8.8.Legacy Health System USA
2.8.9.Good Shepherd Hospital USA
2.8.10.Palmetto Health USA
2.8.11.Holy Name Hospital USA
2.8.12.Catholic Medical Center - KangNam St. Mary's Hospital, patients and staff Korea
2.8.13.Bronson Healthcare Group, patients and staff USA
2.8.14.Nottingham University Hospitals NHS Trust assets UK
2.9.Miyake white navigation system
2.10.Verichip Hugs and Kisses tags for mother baby matching
2.11.Hospital contact history and monitoring system
2.12.Overall strategic design
2.13.Patient track & alarm
2.14.Information systems in Wirral Hospital
2.15.Analysis - EDR/EIS
2.16.Radianse RTLS tags
2.17.A selection of UWB RFID tags
2.18.GSH equipment rental costs
2.19.GSH equipment purchasing costs
2.20.GSH associate satisfaction
2.21.HealthCare pilot RTLS tags
2.22.How The HealthCare Pilot system works
3.PHARMACEUTICAL ANTICOUNTERFEITING, THEFT CONTROL AND TRACKING
3.1.Some of the leading suppliers and aspiring suppliers of RFID labels for pharmaceuticals.
3.1.Challenges
3.1.The TAGSYS stamp sized HF RFID label fitted to all US shipments of Pfizer Viagra
3.1.1.Solutions to counterfeit pharmaceuticals
3.2.Attitude of legislators and the industry
3.2.Short and Long Term Anticounterfeiting Strategies
3.2.1.Food and Drug Administration USA
3.2.2.FDA U-turn
3.2.3.Actual FDA progress to 2009
3.2.4.European Pharmaceutical Industry
3.2.5.East Asia
3.2.6.Case study Wal-Mart mandate for Type 2 pharmaceuticals
3.2.7.Leadership from Pfizer and other major suppliers
3.2.8.Pharmaceutical theft reduction and tracking
3.3.Case studies
3.3.Avery Dennison UHF smart label for item level drugs
3.3.1.Pfizer Viagra USA
3.3.2.GlaxoSmithKline Trizivir drug item level USA
3.3.3.Abbott Laboratories Wal-Mart USA
3.3.4.Cephalon, tracking pharmaceuticals, France, Germany, UK, USA
3.3.5.CVS Pharmacy USA
3.3.6.Felletti Spadazzi Italy
3.3.7.GS1 Europe
3.3.8.HD Smith USA
3.3.9.Johnson & Johnson USA
3.3.10.McKesson USA
3.3.11.Millennium Pharmaceutical UK
3.3.12.Novartis USA
3.3.13.Purdue Pharma USA
3.3.14.Ranbaxy Pharmaceuticals India
3.3.15.UK Pharmaceutical UK
3.3.16.Unimed Pharma Korea
3.3.17.Walgreens USA
3.3.18.West Pharmaceutical Services USA
3.3.19.Cardinal Health USA
3.3.20.Felletti Spadazzi, drug cases, Italy
3.4.Suppliers capabilities
3.4.915 MHz EPC tag on item level drugs packages from Abbott Laboratories in the Accenture trials. The EPC code was only printed on the outside for the first phase (see bottom of label).
4.ERROR REDUCTION, RECORDING PROCEDURES, PATIENT COMPLIANCE
4.1.Telemetry technologies available and their drawbacks for patient monitoring
4.1.Error reduction and recording procedures
4.1.Usage and background data is read from the device and logged
4.1.1.Electronic handshake to prevent mismatching of patient to treatment
4.1.2.Human implants for instant medical record of high risk patients
4.2.Patient compliance
4.2.Luer connectors in 'wrong' configuration
4.2.2.Bang & Olufsen Medicaid, Denmark
4.2.3.Precision Dynamics, USA
4.2.4.Brenmoor UK
4.2.5.Stora Enso
4.3.Case studies
4.3.Luer connectors in 'correct' configurations
4.3.1.Fischer Clinical Services drug trials item level, USA
4.3.2.Melexis, Belgium
4.3.3.AstraZeneca, UK
4.3.4.Baptist Health USA
4.3.5.Veterans V/A Hospitals USA
4.3.6.Regenesis Biomedical USA
4.3.7.Mediplus, UK
4.3.8.South Tyneside Healthcare Trust UK
4.4.Traceability / medical devices in a manufacturer/distributor
4.5.Traceability / medical devices within a hospital situation
4.6.Level of non-compliance for different medical treatments
4.7.Patient compliance blisterpack from Information Mediary Canada
4.8.Precision Dynamics RFID wristband
4.9.What is Smart Band?
4.10.Hospital architecture model
4.11.Patient information data pipeline
4.12.Smart Band solutions at work through the complete patient care process
4.13.On-the-fly calibration - just show the bottom of the container to the glucometer
4.14.Glucometer application in detail - the MLX90109 reader
4.15.Glucometer application in detail - the MLX90127 sticky label transponder
4.16.Diprivan TCI tag construction
4.17.Tagged syringe and Diprifusor™
4.18.Pill bottle with smart label (printed prescription label not shown)
4.19.ScripTalk speaker
4.20.Mediplus tagged catheter
4.21.Mediplus Pressflow overview
5.MANAGEMENT OF BLOOD, SUPPLIES, EQUIPMENT
5.1.Blood testing, transport and transfusion
5.1.Uchida Yoko's 'Pick up by light' system
5.2.Tag with LED - File by Light system. The LED is in the top left corner
5.2.Smart cabinets
5.2.1.Electrolux, Germany
5.3.Laundry - rented textiles
5.3.Applying Coil-on-Chip to hearing aids
5.4.Square CoC tag chip enclosed in protective plastic coating
5.4.Document management
5.4.1.Uchida Yoko, Japan
5.4.2.Yoshikawa, Japan
5.5.Hearing aids
5.5.How the intelliaid™ system works
5.6.Intelliaid™ scanners
5.6.Case studies
5.6.1.Massachusetts General Hospital, blood USA
5.6.2.Portsmouth General Hospital, blood UK
5.6.3.Georgetown University Hospital, blood USA
5.6.4.Saarbrucken Clinic, blood Germany
5.6.5.St James Hospital Ireland
5.6.6.Medline Industries, surgical disposables, USA
5.7.Supplier capability
5.7.Paling Risk Scale for major transfusion hazards
5.7.1.Hitachi, Japan
5.7.2.DHL healthcare logistics Europe
5.8.SHOT project: cumulative data 1996 to 2001
5.9.Increasing errors within hospitals
5.10.Safe transfusion: Processes not just product
5.11.Automated warning generated when a possible mis-match of blood and patient occurs
5.12.RFID on blood container, next to interrogator
5.13.Blood labelled with RFID chip
5.14.The process - blood sampling
5.15.The process - pathology laboratory
5.16.The benefits - supporting change
5.17.Identifying patients and their blood
5.18.Hitachi CoC blood donor card
5.19.The card is flexible
5.20.CoC tags as cards or tokens shown in interrogators
5.21.Hitachi tagged test tube
5.22.Hitachi multihead antenna array, a form of 'smart shelf'
5.23.TAGSYS item level HF label
5.24.DHL in the healthcare supply chain
5.25.DHL RFID Pilot Experience & Development Areas
6.OTHER USES FOR RFID IN HEALTHCARE
6.1.Secure access
6.1.Comparison of the two types of RFID smart card
6.1.Principle of Miyake foot key system for secure access by staff
6.2.Principle of Miyake foot key system for control of disoriented elderly
6.2.Comparison of RFID shoes, wristbands and implants for secure access
6.2.Recording and alerting to incidents
6.3.Case studies
6.3.Hospital staff with the Connexion2 alarm/ record device
6.3.1.NHS Security Management Service, staff safety UK
6.3.2.Hospital La Conception, pathology samples France
6.3.3.Human Fertilisation and Embryology Authority (HFEA), embryos, eggs, sperm UK
6.3.4.Paoli Calmette Institute, pathology samples Italy
6.3.5.Hart District Council, safety of disabled at home UK
6.4.The reverse of the Connexion2 device showing the button that activates remote recording
6.5.HF tags from TAGSYS
6.6.Alarm button on the active RFID pendant
7.MARKET FORECASTS
7.1.Total RFID market 2009-2019
7.1.Assumptions for forecasts of healthcare and pharmaceuticals RFID market 2009-2019
7.1.Passive tags number million sold globally for healthcare and pharmaceuticals 2009-2019
7.2.Passive tags for healthcare and pharmaceuticals unit price cents 2009-2019
7.2.Passive tags number million sold globally for healthcare and pharmaceuticals 2009-2019
7.2.Healthcare and pharmaceutical RFID market 2009-2019
7.2.2.Potential for RFID on prescription drugs
7.3.Passive tags for healthcare and pharmaceuticals value dollar millions 2009-2019
7.3.RTLS market 2009-2019
7.3.Passive tags for healthcare and pharmaceuticals unit price cents 2009-2019
7.4.Passive tags for healthcare and pharmaceuticals value dollar millions 2009-2019
7.4.Active tags for healthcare and pharmaceuticals number million 2009-2019
7.5.Active tags for healthcare and pharmaceuticals unit price cents 2009-2019
7.5.Active tags for healthcare and pharmaceuticals number million 2009-2019
7.6.Active tags for healthcare and pharmaceuticals unit price cents 2009-2019
7.6.Active tags for healthcare and pharmaceuticals value dollars millions 2009-2019
7.7.RTLS as a percentage of the active RFID market in 2009 by value
7.7.Active tags for healthcare and pharmaceuticals value dollars millions 2009-2019
7.8.Chipless percentage share of the overall RFID market by numbers 2009 to 2019. Projection by IDTechEx
7.8.RTLS as a percentage of the active RFID market in 2019 by value
7.9.Addressable market in billions yearly as a function of tag price
APPENDIX 1: IDTECHEX PUBLICATIONS AND RESEARCH
APPENDIX 2: CONTACT DETAILS
APPENDIX 3: INTRODUCTION TO RFID
APPENDIX 4: RFID SOLUTION PROVIDERS
TABLES
FIGURES
 

About IDTechEx reports

What are the qualifications of the people conducting IDTechEx research?

Content produced by IDTechEx is researched and written by our technical analysts, each with a PhD or master's degree in their specialist field, and all of whom are employees. All our analysts are well-connected in their fields, intensively covering their sectors, revealing hard-to-find information you can trust.

How does IDTechEx gather data for its reports?

By directly interviewing and profiling companies across the supply chain. IDTechEx analysts interview companies by engaging directly with senior management and technology development executives across the supply chain, leading to revealing insights that may otherwise be inaccessible.
 
Further, as a global team, we travel extensively to industry events and companies to conduct in-depth, face-to-face interviews. We also engage with industry associations and follow public company filings as secondary sources. We conduct patent analysis and track regulatory changes and incentives. We consistently build on our decades-long research of emerging technologies.
 
We assess emerging technologies against existing solutions, evaluate market demand and provide data-driven forecasts based on our models. This provides a clear, unbiased outlook on the future of each technology or industry that we cover.

What is your forecast methodology?

We take into account the following information and data points where relevant to create our forecasts:
  • Historic data, based on our own databases of products, companies' sales data, information from associations, company reports and validation of our prior market figures with companies in the industry.
  • Current and announced manufacturing capacities
  • Company production targets
  • Direct input from companies as we interview them as to their growth expectations, moderated by our analysts
  • Planned or active government incentives and regulations
  • Assessment of the capabilities and price of the technology based on our benchmarking over the forecast period, versus that of competitive solutions
  • Teardown data (e.g. to assess volume of materials used)
  • From a top-down view: the total addressable market
  • Forecasts can be based on an s-curve methodology where appropriate, taking into account the above factors
  • Key assumptions and discussion of what can impact the forecast are covered in the report.

How can I be confident about the quality of work in IDTechEx reports?

Based on our technical analysts and their research methodology, for over 25 years our work has regularly received superb feedback from our global clients. Our research business has grown year-on-year.
 
Recent customer feedback includes:
"It's my first go-to platform"
- Dr. Didi Xu, Head of Foresight - Future Technologies, Freudenberg Technology Innovation
 
"Their expertise allows us to make data-driven, strategic decisions and ensures we remain aligned with the latest trends and opportunities in the market."
- Ralf Hug, Global Head of Product Management & Marketing, Marquardt

What differentiates IDTechEx reports?

Our team of in-house technical analysts immerse themselves in industries over many years, building deep expertise and engaging directly with key industry players to uncover hard-to-find insights. We appraise technologies in the landscape of competitive solutions and then assess their market demand based on voice-of-the-customer feedback, all from an impartial point of view. This approach delivers exceptional value to our customers—providing high-quality independent content while saving customers time, resources, and money.

Why should we pick IDTechEx research over AI research?

A crucial value of IDTechEx research is that it provides information, assessments and forecasts based on interviews with key people in the industry, assessed by technical experts. AI is trained only on content publicly available on the web, which may not be reliable, in depth, nor contain the latest insights based on the experience of those actively involved in a technology or industry, despite the confident prose.

How can I justify the ROI of this report?

Consider the cost of the IDTechEx report versus the time and resources required to gather the same quality of insights yourself. IDTechEx analysts have built up an extensive contact network over many years; we invest in attending key events and interviewing companies around the world; and our analysts are trained in appraising technologies and markets.
 
Each report provides an independent, expert-led technical and market appraisal, giving you access to actionable information immediately, rather than you having to spend months or years on your own market research.

Can I speak to analysts about the report content?

All report purchases include up to 30 minutes of telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.

What is the difference between a report and subscription?

A subscription from IDTechEx can include more reports, access to an online information platform with continuously updated information from our analysts, and access to analysts directly.

Before purchasing, I have some questions about the report, can I speak to someone?

Please email research@idtechex.com stating your location and we will quickly respond.

About IDTechEx

Who are IDTechEx's customers?

IDTechEx has served over 35,000 customers globally. These range from large corporations to ambitious start-ups, and from Governments to research centers. Our customers use our work to make informed decisions and save time and resources.

Where is IDTechEx established?

IDTechEx was established in 1999, and is headquartered in Cambridge, UK. Since then, the company has significantly expanded and operates globally, having served customers in over 80 countries. Subsidiary companies are based in the USA, Germany and Japan.

Questions about purchasing a report

How do I pay?

In most locations reports can be purchased by credit card, or else by direct bank payment.

How and when do I receive access to IDTechEx reports?

When paying successfully by credit card, reports can be accessed immediately. For new customers, when paying by bank transfer, reports will usually be released when the payment is received. Report access will be notified by email.

How do I assign additional users to the report?

Users can be assigned in the report ordering process, or at a later time by email.

Can I speak to someone about purchasing a report?

Please email research@idtechex.com stating your location and we will quickly respond.
 
The market for RFID tags and systems in healthcare will be $94.6 million in 2009

Report Statistics

Pages 290
Tables Over 45
Figures Over 100
Case Studies Over 70
Forecasts to 2019
 

Customer Testimonial

quote graphic
"IDTechEx consistently provides well-structured and comprehensive research reports, offering a clear and holistic view of key trends... It's my first go-to platform for quickly exploring new topics and staying updated on industry advancements."
Head of Foresight - Future Technologies
Freudenberg Technology Innovation SE & Co. KG
 
 
 

Subscription Enquiry